The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121305894 12130589 4 F 20160217 20160714 20160301 20160718 EXP JP-JNJFOC-20160225319 JANSSEN 80.66 YR E M Y 54.00000 KG 20160718 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121305894 12130589 1 PS ZYTIGA ABIRATERONE ACETATE 1 Oral Y N 202379 1000 MG TABLET QD
121305894 12130589 2 SS CARBOPLATIN. CARBOPLATIN 1 Intravenous (not otherwise specified) U 0 220 MG INJECTION QD
121305894 12130589 3 SS TS-1 GIMERACILOTERACILTEGAFUR 1 Oral U 0 40 MG TABLET BID
121305894 12130589 4 C PREDNISOLONE. PREDNISOLONE 1 Oral 0 10 MG TABLET QD
121305894 12130589 5 C ABSTRAL FENTANYL CITRATE 1 Sublingual 0 100 MG TABLET QD
121305894 12130589 6 C FAMOTIDINE. FAMOTIDINE 1 Oral 0 10 MG TABLET BID
121305894 12130589 7 C MAGLAX MAGNESIUM OXIDE 1 Oral 0 330 MG TABLET BID
121305894 12130589 8 C ONBREZ INDACATEROL 1 Respiratory (inhalation) 0 1 G CAPSULE QD
121305894 12130589 9 C FENTOS FENTANYL 1 Transdermal 0 1 MG TAPE QD
121305894 12130589 10 C NAPROXEN. NAPROXEN 1 Oral 0 100 MG TABLET TID
121305894 12130589 11 C ARGAMATE CALCIUM POLYSTYRENE SULFONATE 1 Oral 0 25 G GEL BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121305894 12130589 1 Hormone-refractory prostate cancer
121305894 12130589 2 Squamous cell carcinoma of lung
121305894 12130589 3 Squamous cell carcinoma of lung
121305894 12130589 4 Hormone-refractory prostate cancer
121305894 12130589 5 Cancer pain
121305894 12130589 6 Chronic gastritis
121305894 12130589 7 Constipation
121305894 12130589 8 Chronic obstructive pulmonary disease
121305894 12130589 9 Cancer pain
121305894 12130589 10 Tumour associated fever
121305894 12130589 11 Hyperkalaemia

Outcome of event

Event ID CASEID OUTC COD
121305894 12130589 HO
121305894 12130589 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
121305894 12130589 Haematuria
121305894 12130589 Platelet count decreased
121305894 12130589 Prostate cancer
121305894 12130589 Squamous cell carcinoma of lung

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121305894 12130589 1 20160204 20160216 0
121305894 12130589 2 20160122 20160122 0
121305894 12130589 3 20160122 20160204 0
121305894 12130589 4 20160204 20160216 0
121305894 12130589 5 20151207 0
121305894 12130589 6 20160222 0
121305894 12130589 7 20160222 0
121305894 12130589 8 20160222 0
121305894 12130589 9 20151207 20160221 0
121305894 12130589 10 20151218 20160222 0
121305894 12130589 11 20151225 20160222 0